Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Plos One|August 26, 2020
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trialPaul Jank, Claire Gehlhaar, Lederer Bianca, et al.
Plos One|September 1, 2021
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trialPaul Jank, Claire Gehlhaar, Bianca Lederer, et al.
British Journal of Cancer|July 21, 2022
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassificationSebastian Foersch, Corinna Lang-Schwarz, Markus Eckstein, et al.
NPJ Breast Cancer|May 14, 2025
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantificationKristin Galas, Moritz Gleitsmann, Julia Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical TrialsPaul Jank, Thomas Karn, Marion van Mackelenbergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto TrialSibylle Loibl, Denise Treue, Jan Budczies, et al.
Virchows Archiv : an International Journal of Pathology|April 23, 2026
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identificationPaul Jank, Maximilian J Krämer, Michael Untch, et al.
NPJ Breast Cancer|April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancerMarion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Cancers|September 28, 2021
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality AssessmentRamona Erber, Arndt Hartmann, Peter Andreas Fasching, et al.
The Journal of Pathology|April 16, 2019
Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesiclesMaren Voglstaetter, Andreas R Thomsen, Jerome Nouvel, et al.
Pageof 5